|Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women|
QA Karim, SSA Karim, JA Frohlich, AC Grobler, C Baxter, LE Mansoor, ...
science 329 (5996), 1168-1174, 2010
|The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection|
ES Gray, MC Madiga, T Hermanus, PL Moore, CK Wibmer, NL Tumba, ...
Journal of virology 85 (10), 4828-4840, 2011
|Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants|
MR Abrahams, JA Anderson, EE Giorgi, C Seoighe, K Mlisana, LH Ping, ...
Journal of virology 83 (8), 3556-3567, 2009
|Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern …|
M Li, JF Salazar-Gonzalez, CA Derdeyn, L Morris, C Williamson, ...
Journal of virology 80 (23), 11776-11790, 2006
|Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection|
ES Gray, PL Moore, IA Choge, JM Decker, F Bibollet-Ruche, H Li, ...
Journal of virology 81 (12), 6187-6196, 2007
|Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study|
GE Gray, M Allen, Z Moodie, G Churchyard, LG Bekker, M Nchabeleng, ...
The Lancet infectious diseases 11 (7), 507-515, 2011
|Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa|
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
|Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection|
PL Moore, N Ranchobe, BE Lambson, ES Gray, E Cave, MR Abrahams, ...
PLoS Pathog 5 (9), e1000598, 2009
|Transmission of extensively drug-resistant tuberculosis in South Africa|
NS Shah, SC Auld, JCM Brust, B Mathema, N Ismail, P Moodley, ...
New England Journal of Medicine 376 (3), 243-253, 2017
|Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression|
L Roberts, JAS Passmore, C Williamson, F Little, LM Bebell, K Mlisana, ...
AIDS (London, England) 24 (6), 819, 2010
|Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal|
KA Cohen, T Abeel, AM McGuire, CA Desjardins, V Munsamy, TP Shea, ...
PLoS Med 12 (9), e1001880, 2015
|Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study|
F Van Loggerenberg, K Mlisana, C Williamson, SC Auld, L Morris, ...
PloS one 3 (4), e1954, 2008
|The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection|
PL Moore, ES Gray, IA Choge, N Ranchobe, K Mlisana, SSA Karim, ...
Journal of virology 82 (4), 1860-1869, 2008
|Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa|
K Mlisana, N Naicker, L Werner, L Roberts, F Van Loggerenberg, ...
The Journal of infectious diseases 206 (1), 6-14, 2012
|Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop|
PL Moore, ES Gray, D Sheward, M Madiga, N Ranchobe, Z Lai, ...
Journal of virology 85 (7), 3128-3141, 2011
|Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage|
DR Chopera, Z Woodman, K Mlisana, M Mlotshwa, DP Martin, C Seoighe, ...
PLoS Pathog 4 (3), e1000033, 2008
|Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study|
L Masson, K Mlisana, F Little, L Werner, NN Mkhize, K Ronacher, ...
Sexually transmitted infections 90 (8), 580-587, 2014
|Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance|
CA Desjardins, KA Cohen, V Munsamy, T Abeel, K Maharaj, BJ Walker, ...
Nature genetics 48 (5), 544-551, 2016
|Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study|
GE Gray, Z Moodie, B Metch, PB Gilbert, LG Bekker, G Churchyard, ...
The Lancet infectious diseases 14 (5), 388-396, 2014
|Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region|
ES Gray, MC Madiga, PL Moore, K Mlisana, SSA Karim, JM Binley, ...
Journal of virology 83 (21), 11265-11274, 2009